However, you don’t have to be an expert in flow cytometry to achieve reproducible and reliable results. Learn everything you need to improve your flow cytometry experiments and gain confidence in your results in less than one hour.

Traditional organoid culture can present challenges for the downstream analysis of single organoids. In this webinar, Dr. Allysa Stern will discuss a unique workflow that enables clonal organoid development, monitoring of iPSC differentiation over time and automated isolation of single organoids.

Dr. Scott Magness will then present a case related to his group’s work investigating tumor cell heterogeneity through clonal organoid morphology and transcriptomics. He will discuss new approaches using single organoid transcriptomics to evaluate organoids derived from single cells from gastric dysplastic tissues and how this approach might reveal new ways to investigate tumor cell heterogeneity and evasion of some cells from cancer treatments.

Modern gene editing technologies continue to transform biological research and push the boundaries of what is possible in and out of the lab. This free-to-attend event will provide industry and academic researchers with a platform to discuss some of the most exciting ways gene editing technologies are being deployed to address real-world challenges in areas spanning human health, agriculture, and climate change.

During this webinar, you will discover ways to improve your protein extraction, such as by reducing workflow complexity, improving results from scarce samples, setting up robust assays and working with large sample cohorts.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.

This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.

From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.

The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.